Patent details

EP2269631 Title: Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics

Basic Information

Publication number:
EP2269631
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100106863
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
French Title of Invention:
Compositions pharmaceutiques comportant de la neurotoxine botulique à utilisation médicale et cosmétique
German Title of Invention:
Pharmazeutische Zusammensetzungen, die Botulinum-Neurotoxin enthalten, zur Verwendung in der Medizin und in der Kosmetik
SPC Number:

Dates

Filing date:
06/07/2005
Grant date:
09/10/2013
EP Publication Date:
05/01/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/01/2011
EP B1 Publication Date:
09/10/2013
EP B2 Publication Date:
12/06/2019
EP B3 Publication Date:
Lapsed date:
06/07/2014
Expiration date:
06/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/06/2019
 
 

Name:
Ipsen Biopharm Limited
Address:
Ash Road, Wrexham Industrial Estate,, Wrexham LL13 9UF, United Kingdom (GB)

Inventor

1

Name:
Partington, Julie
Address:
United Kingdom (GB)

2

Name:
White, Mary
Address:
United Kingdom (GB)

3

Name:
Webb, Paul
Address:
United Kingdom (GB)

Priority

Priority Number:
0415491
Priority Date:
12/07/2004
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/00; A61K 9/19; A61K 38/48; A61K 47/26; A61K 47/30;

Publication

European Patent Bulletin

Issue number:
201924
Publication date:
12/06/2019
Description:
Patent maintained (B2 publication)
Filing date Document type Number of pages